Tempus Al TEM 深 滬
等待開盤 08-21 09:30:00 美东时间
66.65
+5.400
+8.82%
華盛通- 最 高68.96
- 今 開61.83
- 成交量 2014.30万股
- 最 低 61.70
- 昨 收 61.25
- 總市值 120.26亿
- 52周最高 104.32
- 市盈率 靜 --
- 換手率 11.16%
- 52周最低 40.77
- 委 比 -98.48%
- 總股本 1.80亿
- 歷史最高 104.32
- 量 比 2.94
- 振 幅 11.85%
- 歷史最低 22.89
- 每 手 1
- 風險率 14.81%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 塔吉特获13家大行上调目标价；Moderna携手默沙东齐获大行上调目标价
今日重点评级关注：康托·菲茨杰拉德：维持Ultragenyx Pharmaceutical"超配"评级，目标价从96美元升至103美元；Canaccord Genuity：维持Ultragenyx Pharmaceutical"买入"评级，目标价从81美元升至83美元
今天 11:40
Why Is Tempus AI Stock Gaining Thursday?
Tempus AI Inc. (NASDAQ:TEM) stock is trading higher Thursday, extending gains from the previous session. BTIG maintained a Buy rating on Tempus AI on Thursday and raised its price forecast to $80. Investors are also linking a major cancer trial milestone to Tempus AI’s pending $1.5 billion acquisiti...
08-20 20:35
BTIG Maintains Buy on Tempus AI, Raises Price Target to $80
BTIG analyst Mark Massaro maintains Tempus AI (NASDAQ:TEM) with a Buy and raises the price target from $70 to $80.
08-20 19:06
Moderna暴涨177%！mRNA癌症疫苗迎来“ChatGPT时刻”？16只港美标的谁会接过下一棒？
Moderna暴涨177%！mRNA癌症疫苗迎来“ChatGPT时刻”？大行密集上调目标价，最快2027年有望商业化；16只港美标的谁会接过下一棒？>>
08-20 18:45
美股牛股 | Moderna狂飙177%！美银火速将其目标价翻两番；油气股SOC升近20%
Moderna狂飙177%！美银火速将其目标价翻两番，TEM、BNTX受利好分别升24%、22%；；油气股SOC升近20%，法院裁定其加州管道重启工作将继续进行>>
08-20 16:20
Tempus AI Soars as Merck-Moderna Cancer Trial Validates Personalis Acquisition
Shares of Tempus AI Inc (NASDAQ:TEM) are surging Wednesday morning as traders connected the dots between a landmark clinical trial win and Tempus’s recent multi-billion dollar acquisition deal. Here’s what investors need to know. Tempus AI stock is surging to new heights today. What’s behind TEM gai...
08-19 22:57
Estee Lauder, Moderna, Merck And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were mixed, with the Dow Jones index gaining over 200 points on Wednesday. Shares of Estee Lauder Companies Inc (NYSE:EL) rose sharply after the company reported better-than-expected fourth-quarter financial results and issued its FY27 sales guidance with its midpoint above estimates. Ad...
08-19 22:08
CellCarta Adds Tempus to CDx Commercialization Lab Network
Tempus joins as a second commercial laboratory partnership to support oncology-focused access within CellCarta's CDx Accelerator Model. MONTREAL, Aug. 6, 2026 /PRNewswire/ -- CellCarta, a gl...
08-06 21:15
美股大行评级 | 潜在涨幅3586.64%！HC Wainwright上调Enlivex目标价至80美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Enlivex"买入"评级，目标价从20美元升至80美元；Canaccord Genuity：维持Pharming Group NV Sponsored ADR"买入"评级，目标价从37美元升至38美元
08-04 11:45
Stifel Maintains Hold on Tempus AI, Lowers Price Target to $50
Stifel analyst Daniel Arias maintains Tempus AI (NASDAQ:TEM) with a Hold and lowers the price target from $60 to $50.
08-03 20:06
